Table 4.
Biopsy specimens | Surgical specimens | |
---|---|---|
mPFS | ||
Homo-HER2 | 10.8 (95% CI 6.9–19.4) | 20.0 (95% CI 17.8–22.2) |
Hetero-HER2 | 6.1 (95% CI 5.3–8.2) | 6.0 (95% CI 2.3–9.7) |
mOS | ||
Homo-HER2 | 29.3 (95% CI 20.5–NR) | NR |
Hetero-HER2 | 14.4 (95% CI 11.4–17.8) | 14.0 (95% CI 11.9–16.1) |
mPFS Median progression-free survival, mOS median overall survival, NR not reached, Homo-HER2 homogeneously HER2 positive, Hetero-HER2 heterogeneously HER2 positive